CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

Neutral
AI Analysis

Summary

Edgewise Therapeutics announced the grant of inducement stock awards on September 30, 2026, in accordance with Nasdaq Listing Rules.

Importance:2/10
Sentiment:
0.00
equityinducement grantsNasdaq rules
Related Companies

Read the original article

Published by PR Newswire Biotech on October 1, 2026 12:00 PM

Read Original